Table 1.
placebo + propofol | ketamine + propofol | p | |
---|---|---|---|
n | 16 | 11 | |
Age (years) | 59.60 (15.71) | 57.34 (13.02) | 0.69 |
Gender M/F | 9/7 | 7/4 | 0.70 |
Unipolar/bipolar depression (n) | 13/3 | 11/0 | 0.25 |
Treatment resistant depression (n) | 13 | 11 | 0.25 |
MADRS score | 35.44 (4.77) | 36.73 (8.81) | 0.62 |
MMSE score | 27.4 (2.4) | 26.7 (4.7) | 0.66 |
Prior suicide attempts (n) | 0.5 (0.9) | 1.5 (1.4) | 0.07 |
ECT parameters | |||
Seizure threshold (mC) | 119.7 (109.8) | 94.40 (62.15) | 0.51 |
Number of sessions | 9.62 (4.51) | 10.18 (4.42) | 0.75 |
EEG seizure duration (s) | 29.42 (12.66) | 20.12 (6.82) | 0.036* |
Clinical seizure duration (s) | 19.95 (9.74) | 12.54 (3.78) | 0.025* |
RUL/BT | 6/10 | 5/6 | 0.68 |
The results are given as the mean (standard deviation).
RUL, right unilateral; BT, bitemporal.
*means statistically significant.